The RegiSONIC Disease Registry Study: Safety and effectiveness of vismodegib or surgery as primary treatment in patients with locally advanced basal cell carcinoma Meeting Abstract


Authors: Lacouture, M.; Guillen, J.; Kudchadkar, R.; Rogers, G.; Olencki, T.; Tang, J. Y.; Yoo, S.; Dawson, K.; Mun, Y.; Sekulic, A.
Abstract Title: The RegiSONIC Disease Registry Study: Safety and effectiveness of vismodegib or surgery as primary treatment in patients with locally advanced basal cell carcinoma
Meeting Title: 18th European Cancer Conference (ECCO 18)
Journal Title: European Journal of Cancer
Volume: 51
Issue: Suppl. 3
Meeting Dates: 2015 Sep 25-29
Meeting Location: Vienna, Austria
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S679
End Page: S680
Language: English
ACCESSION: WOS:000361887403179
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)31859-7
Notes: Meeting Abstract: 3341 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture